Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus

Virology
Troy C Sutton, Kanta Subbarao

Abstract

Two novel coronaviruses have emerged to cause severe disease in humans. While bats may be the primary reservoir for both viruses, SARS coronavirus (SARS-CoV) likely crossed into humans from civets in China, and MERS coronavirus (MERS-CoV) has been transmitted from camels in the Middle East. Unlike SARS-CoV that resolved within a year, continued introductions of MERS-CoV present an on-going public health threat. Animal models are needed to evaluate countermeasures against emerging viruses. With SARS-CoV, several animal species were permissive to infection. In contrast, most laboratory animals are refractory or only semi-permissive to infection with MERS-CoV. This host-range restriction is largely determined by sequence heterogeneity in the MERS-CoV receptor. We describe animal models developed to study coronaviruses, with a focus on host-range restriction at the level of the viral receptor and discuss approaches to consider in developing a model to evaluate countermeasures against MERS-CoV.

Associated Clinical Trials

References

Apr 3, 2003·The New England Journal of Medicine·Susan M PoutanenUNKNOWN Canadian Severe Acute Respiratory Syndrome Study Team
Apr 3, 2003·The New England Journal of Medicine·Kenneth W TsangKar N Lai
Apr 12, 2003·The New England Journal of Medicine·Thomas G KsiazekUNKNOWN SARS Working Group
Apr 25, 2003·Lancet·J S M PeirisUNKNOWN SARS study group
May 8, 2003·JAMA : the Journal of the American Medical Association·Christopher M BoothAllan S Detsky
May 16, 2003·Nature·Ron A M FouchierAlbert D M E Osterhaus
Jun 5, 2003·Lancet·John M NichollsJ S Malik Peiris
Jul 8, 2003·The Journal of Pathology·Yanqing DingKaitai Yao
Sep 23, 2003·Science·Dennis Normile, Gretchen Vogel
Oct 31, 2003·Nature·Byron E E MartinaAlbert D M E Osterhaus
Jan 27, 2004·American Journal of Epidemiology·J KarlbergW Y Y Lai
Jan 31, 2004·Science·UNKNOWN Chinese SARS Molecular Epidemiology Consortium
Apr 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Himani BishtBernard Moss
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ursula J BuchholzPeter L Collins
Jun 29, 2004·Lancet·Jan ter MeulenAlbert D M E Osterhaus
Aug 25, 2004·Emerging Infectious Diseases·David E WentworthKristen A Bernard
Sep 29, 2004·Journal of Virology·Thomas RoweJames M Wilson
Oct 22, 2004·Proceedings of the National Academy of Sciences of the United States of America·Scott A JeffersKathryn V Holmes
Oct 27, 2004·Emerging Infectious Diseases·Guodong LiangUNKNOWN SARS Diagnosis Working Group
Dec 15, 2004·Journal of Virology·Anjeanette RobertsKanta Subbarao
Mar 26, 2005·The EMBO Journal·Wenhui LiMichael Farzan
Sep 20, 2005·Proceedings of the National Academy of Sciences of the United States of America·Susanna K P LauKwok-Yung Yuen
Apr 12, 2006·PLoS Medicine·James V LawlerJason Paragas
Jan 16, 2007·PLoS Pathogens·Anjeanette RobertsKanta Subbarao
May 15, 2007·Virus Research·Anjeanette RobertsKanta Subbarao
Oct 9, 2007·The Journal of Infectious Diseases·Miriam E R DarnellDeborah R Taylor
May 2, 2008·Vector Borne and Zoonotic Diseases·D M WattsP R Wyde

❮ Previous
Next ❯

Citations

Feb 13, 2016·Nature Reviews. Drug Discovery·Alimuddin ZumlaKwok-Yung Yuen
May 24, 2015·Paediatric Respiratory Reviews·G R BanikH Rashid
Dec 22, 2016·Cell and Tissue Research·Andreas C HockeStefan Hippenstiel
Mar 3, 2018·Viruses·Aasiyah Chafekar, Burtram C Fielding
Mar 9, 2019·Expert Opinion on Drug Discovery·Allison L Totura, Sina Bavari
Mar 13, 2020·Journal of Clinical Microbiology·Suliman KhanMengzhou Xue
May 8, 2020·Emerging Microbes & Infections·Lunzhi YuanNingshao Xia
Apr 26, 2020·British Journal of Pharmacology·Krishna Sriram, Paul A Insel
Jun 12, 2020·Future Microbiology·Meixian Wang, Nannan Zhang
Sep 17, 2019·Risk Analysis : an Official Publication of the Society for Risk Analysis·Umesh AdhikariJade Mitchell
Aug 3, 2020·Immunology and Cell Biology·Marios KoutsakosKatherine Kedzierska
Sep 3, 2017·Biotechnology Journal·Katja ZscheppangAndreas C Hocke
Apr 28, 2020·Laboratory animal research·Mee Sook ParkMan-Seong Park
Jul 16, 2020·BMJ Open Gastroenterology·Maria EffenbergerHerbert Tilg
Aug 26, 2020·Expert Review of Vaccines·Raphaël M ZellwegerJerome H Kim
Apr 25, 2020·Infectious Diseases and Therapy·Eriko Padron-Regalado
Oct 8, 2020·Critical Care : the Official Journal of the Critical Care Forum·Salleh N EhaidebAbderrezak Bouchama
Sep 17, 2020·Clinical and Experimental Immunology·John S TregoningKatrina M Pollock
Nov 1, 2020·Transboundary and Emerging Diseases·Kabita PandeySiddappa N Byrareddy
Feb 16, 2021·Research in Veterinary Science·Giacomo RossiSara Mangiaterra
Dec 8, 2020·Virusdisease·Suresh KumarNagarajan Perumal
Nov 3, 2020·Frontiers in Immunology·Salman Sadullah Usmani, Gajendra P S Raghava
Dec 19, 2020·International Journal of Environmental Research and Public Health·Shubhadeep RoychoudhuryPetr Slama
Apr 25, 2020·Infectious Diseases and Therapy·Eriko Padron-Regalado
Mar 2, 2021·Frontiers in Public Health·Christian A DevauxDidier Raoult
Mar 24, 2021·Nature Reviews. Microbiology·Nancy H L Leung
Mar 27, 2021·Scientific Reports·Florian MattenbergerRon Geller
Jun 1, 2021·Journal of Veterinary Science·Han Woong KimYang Kyu Choi
Aug 29, 2021·Pathogens·Alejandro Pascual-IglesiasJose Angel Regla-Nava

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
lavage
glycosylation

Related Concepts

Related Feeds

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.